Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2022 Apr 4;130(4):047701. doi: 10.1289/EHP10288

Exposure to Particle Radioactivity and Breast Cancer Risk in the Sister Study: A U.S.-Wide Prospective Cohort

Alexandra J White 1, Allyson M Gregoire 1, Jared A Fisher 2, Danielle N Medgyesi 2, Longxiang Li 3, Petros Koutrakis 3, Dale P Sandler 1, Rena R Jones 2,
PMCID: PMC8978644  PMID: 35377195

Introduction

Outdoor air pollution has been classified as a human carcinogen.1 The evidence for breast cancer risk is accumulating although the specific constituents driving the association are not well explored.2 Particulate matter can be a vector for radioactive isotopes, most of which arise from naturally occurring radon gas, which has been associated with a higher risk of breast3 and lung cancer.4 We evaluated the association between residential ambient particle radioactivity (PR), a radiometric characteristic of airborne particulate matter, and incident breast cancer.

Methods

The Sister Study cohort includes 50,884 U.S. women ages 35–74 who had a sister diagnosed with breast cancer but no breast cancer history themselves and who were enrolled between 2003–2009. Participants completed an enrollment questionnaire including educational attainment and self-reported race (American Indian/Alaska Native, Asian, Black/African American, Native Hawaiian/Pacific Islander, and White, with the option to select multiple categories) and ethnicity (Hispanic/Latina, with the option to provide country/region of origin). The cohort was approved by the institutional review board of the National Institutes of Health. We used data with follow-up through 23 September 2019 (data release 9.0).

We excluded women with a preenrollment breast cancer diagnosis or who were lost to follow-up (n=363), and those outside the conterminous United States or who were missing covariates (n=1,328) or PR data (n=46), leaving 49,147 women for analysis. Incident breast cancer cases (invasive and ductal carcinoma in situ) were ascertained via self-report and confirmed with medical records.

Ambient PR exposure was estimated using a spatiotemporal ensemble model based on the U.S. Environmental Protection Agency’s Radiation Network (RadNet), a nationwide background environmental radiation monitoring network with gross beta particle activity data collected between 2001 and 2017 from 129 monitors.5 The multistage exposure model incorporates gross beta PR (PR-β) measurements from RadNet and predictors of emissions (e.g., ground-surface uranium, barometric pressure, soil characteristics, anthropogenic sources of radionucleotides) and transport of radon and its progeny [e.g., monthly average fine particulate matter (PM) with aerodynamic diameter 2.5μm (PM2.5), relative humidity, air mass sources]. In the first stage, nine base learning models were selected to characterize the complex associations between particulate radioactivity and its predictors. Stage two used a nonnegative geographically and temporally weighted regression method to aggregate the predictions from the nine base learning models. This ensemble model had good accuracy, with a spatial cross-validation R2=0.56. Estimated monthly levels of PR-β (mBq/m3), a measure of the particle-bound beta-emitting radionuclides, at a 32-km spatial resolution, were averaged to annual estimates at the geocoded enrollment address based on enrollment year.

As described previously, annual average PM with aerodynamic diameter 10μm (PM10), PM2.5, and nitrogen dioxide (NO2) levels were estimated at participant residences using a validated regionalized kriging model with spatial smoothing.2 For PM2.5 and NO2, we used the 2006 annual average because it was a midpoint in the enrollment period (2003–2009). For PM10, we used the 2000 annual average based on data availability and because it predated enrollment.

We used Cox proportional hazards models with age as the time scale to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association with PR-β continuously [per interquartile range (IQR) (0.038 mBq/m3) and per 0.1 mBq/m3 increase] and in quintiles. We evaluated an a priori determined set of potential confounders; models were adjusted for self-reported race/ethnicity (non-Hispanic White, Black/African American including Black Hispanic, and Other, collapsed due to small numbers; “Other” included women who self-identified as non-Black Hispanic, Asian, Native Hawaiian/Pacific Islander, or American Indian/Alaska Native), because determinants of air pollutant exposure may vary by race/ethnicity, and education (high school or less, associate’s degree/technical degree/some college, bachelor’s degree or higher). We also considered a second model adjustment set that further adjusted for PM2.5 (micrograms per cubic meter, μg/m3), PM10 (μg/m3), and NO2 [parts per billion (ppb)]. Models were stratified by estrogen receptor (ER) status. We further stratified associations for an IQR increase and ER– breast cancer by race/ethnicity (non-Hispanic White and Black/African American including Black Hispanic). Associations were also stratified by years lived at the enrollment residence at the time of study baseline (<10y, 10y); heterogeneity was assessed using a likelihood ratio test of cross-product terms. For race-stratified analyses, we did not have the sample size necessary to produce stable estimates for other racial ethnic groups.

Results

With an average of 10 y of follow-up, 3,894 women were diagnosed with breast cancer. The median PR-β was 0.39 mBq/m3. Black women and those with lower educational attainment tended to have higher exposure (Table 1). PR-β varied by census region but did not correlate strongly with residential air pollutants (PM2.5 r=0.2, PM10 r=0.2, NO2 r=0.1).

Table 1.

Population characteristics by quintiles of PRβ exposure in the Sister Study (n=49, 147).

Overall Beta particle radioactivity (PRβ) exposure (mBq/m3) level at baseline residencea
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
Participant characteristicsb Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age at baseline (y) 55.7 (9) 55.9 (8.9) 55.7 (9) 55.3 (9) 55.3 (9) 56.1 (9)
PM2.5 [μg/m3 (2006)] 10.5 (2.4) 9 (2.3) 10.6 (2.5) 11 (2.3) 11.6 (1.9) 10.4 (2.3)
PM10 [μg/m3 (2000)] 22.2 (5.8) 19.4 (4.9) 21.8 (4.9) 23.9 (5.8) 23.7 (6.7) 22.1 (5.1)
NO2 [ppb (2006)] 10.1 (5.0) 9.5 (4.1) 11.3 (4.8) 11.5 (6.3) 10.2 (4.8) 8.1 (3.6)
Race/ethnicity [n (%)] n (%) n (%) n (%) n (%) n (%) n (%)
 Non-Hispanic White 41,922 (85.3%) 8,791 (89.4%) 8,373 (85.2%) 8,127 (82.7%) 8,273 (84.2%) 8,358 (85%)
 Black/African American 4,447 (9%) 446 (4.5%) 939 (9.6%) 1,111 (11.3%) 1,079 (11%) 872 (8.9%)
 Otherc 2,778 (5.7%) 593 (6%) 517 (5.3%) 591 (6%) 477 (4.9%) 600 (6.1%)
Census region
 Northeast 8,441 (17.2%) 3,069 (31.2%) 3,701 (37.7%) 1,270 (12.9%) 166 (1.7%) 235 (2.4%)
 Midwest 13,572 (27.6%) 7 (0.1%) 840 (8.5%) 4,037 (41.1%) 5,704 (58%) 2,984 (30.4%)
 South 16,455 (33.5%) 1,238 (12.6%) 3,127 (31.8%) 2,876 (29.3%) 3,088 (31.4%) 6,126 (62.3%)
 West 10,679 (21.7%) 5,516 (56.1%) 2,161 (22%) 1,646 (16.7%) 871 (8.9%) 485 (4.9%)
Education level
 Less than or equal to high school 7,403 (15.1%) 1,239 (12.6%) 1,378 (14%) 1,538 (15.6%) 1,602 (16.3%) 1,646 (16.7%)
 Associate’s degree/technical degree/some college 16,641 (33.9%) 3,227 (32.8%) 3,086 (31.4%) 3,336 (33.9%) 3,427 (34.9%) 3,565 (36.3%)
 Bachelor’s degree or higher 25,103 (51.1%) 5,364 (54.6%) 5,365 (54.6%) 4,955 (50.4%) 4,800 (48.8%) 4,619 (47%)

Note: ppb, parts per billion; PR, particle radioactivity; PRβ, beta particle radioactivity; SD, standard deviation.

a

PRβ ranges: Quintile 1: 0.277–0.356 mBq/m3; Quintile 2: 0.357–0.378 mBq/m3; Quintile 3: 0.379–0.393 mBq/m3; Quintile 4: 0.394–0.403 mBq/m3; Quintile 5: 0.404–0.514 mBq/m3.

b

Missing values: NO2 (n=70), race/ethnicity (n=11), and education (n=9).

c

Other” race includes women who identified as non-Black Hispanic, Asian, Native Hawaiian/Pacific Islander, or American Indian/Alaska Native.

PR-β was not associated with overall breast cancer risk. Patterns of association were similar with adjustment for residential air pollutants; estimates provided here are fully adjusted (Table 2). When considering the IQR, higher PR-β was suggestively positively related to ER (HRIQR=1.08; 95% CI: 0.96, 1.21) but inversely related to ER+ breast cancer risk (HRIQR=0.96; 95% CI: 0.91, 1.00). Higher PR-β levels were associated with nonmonotonically higher HRs for ER breast cancer in the second, third, and fourth but not the fifth quintiles (HRQ2vsQ1=1.30 95% CI: 0.97, 1.75; HRQ3vsQ1=1.26; 95% CI: 0.92, 1.72; HRQ4vsQ1=1.34 95% CI: 0.98, 1.84; HRQ5vsQ1=1.19, 95% CI: 0.87, 1.62; p-trend=0.4). This association for ER cancers did not significantly vary for non-Hispanic White (case n=418; HRIQR=1.09, 95% CI: 0.97, 1.23) vs. Black/African American women (case n=53; HRIQR=1.00, 95% CI: 0.65, 1.54) (p-for-heterogeneity=0.7), although CIs were wide. HRs for ER cancers were elevated for women who reported living at their baseline residence for 10 y (case n=276; HRIQR=1.15, 95% CI: 0.99, 1.34) in comparison with <10 y (case n=222; HRIQR=1.01, 95% CI: 0.86, 1.18) (p-for-heterogeneity=0.2).

Table 2.

The association between beta particle radioactivity exposure at the baseline address and breast cancer risk overall and by ER status with stratification by time spent at baseline residence.

All participants n Person-years Overall ER positive (+) ER negative (−)
Casesc Age-adjusted
HR (95% CI)
A priori adjusted HR (95% CI)d Fully adjusted (95% CI)e Casesc Age-adjusted HR (95% CI) A priori adjusted HR (95% CI)d Fully adjusted (95% CI)e Casesc Age-adjusted HR (95% CI) A priori adjusted HR (95% CI)d Fully adjusted (95% CI)e,f
Quintile 1a 9,830 106,976 794 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 611 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 81 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Quintile 2 9,829 106,905 798 1.01 (0.91, 1.11) 1.01 (0.91, 1.11) 0.99 (0.89, 1.09) 582 0.96 (0.85, 1.07) 0.96 (0.86, 1.08) 0.94 (0.83, 1.05) 103 1.28 (0.95, 1.71) 1.26 (0.94, 1.68) 1.30 (0.97, 1.75)
Quintile 3 9,829 107,514 753 0.95 (0.86, 1.05) 0.95 (0.86, 1.05) 0.94 (0.84, 1.04) 533 0.88 (0.78, 0.98) 0.9 (0.8, 1.01) 0.87 (0.77, 0.98) 101 1.25 (0.93, 1.67) 1.22 (0.91, 1.64) 1.26 (0.92, 1.72)
Quintile 4 9,829 107,876 791 1.00 (0.91, 1.10) 1.00 (0.91, 1.10) 1.00 (0.89, 1.11) 565 0.93 (0.83, 1.04) 0.95 (0.85, 1.06) 0.94 (0.83, 1.07) 111 1.37 (1.03, 1.82) 1.34 (1.00, 1.79) 1.34 (0.98, 1.84)
Quintile 5 9,830 107,418 758 0.95 (0.86, 1.04) 0.95 (0.86, 1.05) 0.96 (0.87, 1.07) 536 0.87 (0.77, 0.98) 0.89 (0.79, 1.00) 0.91 (0.81, 1.03) 102 1.26 (0.94, 1.68) 1.24 (0.92, 1.66) 1.19 (0.87, 1.62)
p For trend 0.3 0.3 0.6 0.02 0.06 0.2 0.1 0.2 0.4
IQR increaseb 49,147 536,689 3,894 0.98 (0.94, 1.01) 0.98 (0.94, 1.02) 0.98 (0.95, 1.03) 2,827 0.94 (0.90, 0.98) 0.95 (0.91, 0.99) 0.96 (0.91, 1.00) 498 1.11 (1.00, 1.23) 1.10 (0.99, 1.22) 1.08 (0.96, 1.21)
0.1 mBq/m3 increase 49,147 536,689 3,894 0.94 (0.86, 1.04) 0.95 (0.86, 1.04) 0.96 (0.87, 1.07) 2,827 0.85 (0.76, 0.95) 0.87 (0.78, 0.98) 0.89 (0.79, 1.01) 498 1.31 (0.99, 1.72) 1.28 (0.97, 1.69) 1.21 (0.90, 1.63)
<10 y at residence
Quintile 1a 4,505 49,020 358 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 270 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 37 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Quintile 2 4,431 48,137 347 0.99 (0.86, 1.15) 0.99 (0.85, 1.15) 0.98 (0.84, 1.13) 249 0.95 (0.80, 1.12) 0.95 (0.80, 1.13) 0.93 (0.78, 1.10) 48 1.33 (0.87, 2.04) 1.31 (0.85, 2.01) 1.35 (0.87, 2.08)
Quintile 3 4,599 50,138 348 0.96 (0.83, 1.12) 0.96 (0.83, 1.12) 0.95 (0.82, 1.11) 244 0.9 (0.75, 1.06) 0.91 (0.77, 1.08) 0.89 (0.74, 1.06) 40 1.06 (0.68, 1.66) 1.04 (0.67, 1.63) 1.07 (0.67, 1.69)
Quintile 4 4,652 50,883 346 0.94 (0.81, 1.09) 0.94 (0.81, 1.09) 0.94 (0.80, 1.10) 252 0.91 (0.76, 1.08) 0.93 (0.78, 1.10) 0.92 (0.77, 1.10) 49 1.29 (0.84, 1.97) 1.26 (0.82, 1.94) 1.26 (0.81, 1.97)
Quintile 5 5,076 55,226 381 0.93 (0.80, 1.07) 0.93 (0.81, 1.08) 0.95 (0.82, 1.10) 274 0.89 (0.75, 1.05) 0.91 (0.77, 1.07) 0.93 (0.78, 1.11) 48 1.15 (0.75, 1.77) 1.13 (0.74, 1.74) 1.08 (0.70, 1.68)
p For trend 0.2 0.1 0.6 0.3 0.2 0.7 0.4 0.5 1.0
IQR increaseb 23,263 253,404 1,780 0.98 (0.93, 1.03) 0.98 (0.93, 1.03) 0.99 (0.93, 1.04) 1,289 0.96 (0.90, 1.02) 0.97 (0.91, 1.03) 0.98 (0.92, 1.05) 222 1.03 (0.89, 1.20) 1.03 (0.88, 1.20) 1.01 (0.86, 1.18)
0.1 mBq/m3 increase 23,263 253,404 1,780 0.95 (0.83, 1.09) 0.95 (0.83, 1.09 0.97 (0.84, 1.12) 1,289 0.9 (0.77, 1.06) 0.92 (0.78, 1.08 0.95 (0.8, 1.12) 222 1.09 (0.73, 1.62) 1.07 (0.72, 1.6) 1.01 (0.67, 1.53)
10 y at residence
Quintile 1a 5,325 57,956 436 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 341 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 44 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Quintile 2 5,397 58,757 451 1.02 (0.89, 1.16) 1.02 (0.89, 1.16) 1.00 (0.87, 1.14) 333 0.96 (0.83, 1.12) 0.97 (0.84, 1.13) 0.94 (0.81, 1.10) 55 1.23 (0.83, 1.83) 1.22 (0.82, 1.81) 1.26 (0.84, 1.89)
Quintile 3 5,229 57,363 405 0.95 (0.83, 1.08) 0.95 (0.83, 1.08) 0.93 (0.81, 1.06) 289 0.86 (0.74, 1.01) 0.88 (0.76, 1.03) 0.85 (0.72, 1.00) 61 1.4 (0.95, 2.07) 1.37 (0.93, 2.02) 1.43 (0.96, 2.13)
Quintile 4 5,177 56,992 445 1.05 (0.92, 1.20) 1.05 (0.92, 1.20) 1.04 (0.91, 1.20) 313 0.94 (0.81, 1.10) 0.97 (0.83, 1.13) 0.96 (0.81, 1.12) 62 1.43 (0.97, 2.11) 1.40 (0.95, 2.07) 1.41 (0.94, 2.11)
Quintile 5 4,754 52,192 377 0.96 (0.84, 1.10) 0.96 (0.84, 1.11) 0.98 (0.85, 1.13) 262 0.85 (0.73, 1.00) 0.87 (0.74, 1.03) 0.90 (0.76, 1.06) 54 1.37 (0.92, 2.04) 1.35 (0.90, 2.01) 1.29 (0.86, 1.95)
p For trend 0.8 0.06 0.08 0.8 0.1 0.1 1.0 0.3 0.2
IQR increaseb 25,882 283,260 2,114 0.98 (0.93, 1.03) 0.98 (0.93, 1.03) 0.98 (0.93, 1.04) 1,538 0.92 (0.87, 0.98) 0.93 (0.88, 0.99) 0.94 (0.88, 1.00) 276 1.18 (1.02, 1.37) 1.17 (1.01, 1.36) 1.15 (0.99, 1.34)
0.1 mBq/m3 increase 25,882 283,260 2,114 0.94 (0.82, 1.08) 0.94 (0.83, 1.08) 0.96 (0.83, 1.10) 1,538 0.81 (0.69, 0.94) 0.83 (0.71, 0.97) 0.85 (0.72, 1.00) 276 1.55 (1.06, 2.28) 1.52 (1.04, 2.24) 1.44 (0.97, 2.15)

Note: —, no data; CI, confidence interval; ER, estrogen receptor; HR, hazard ratio; IQR, interquartile range; PR, particle radioactivity; PRβ, beta particle radioactivity; Ref, reference.

a

PRβ ranges: Quintile 1: 0.277−0.356 mBq/m3; Quintile 2: 0.357−0.378 mBq/m3; Quintile 3: 0.379−0.393 mBq/m3; Quintile 4: 0.394−0.403 mBq/m3; Quintile 5: 0.404−0.514 mBq/m3.

b

IQR is 0.038 mBq/m3 for baseline address.

c

n=569 women were missing ER status.

d

Adjusted for race (non-Hispanic White, Black/African American, other race including women who identified as non-Black Hispanic, Asian, Native Hawaiian/Pacific Islander, or American Indian/Alaska Native) and education (less than or equal to high school; associate’s degree/technical degree/some college; bachelor’s degree or higher).

e

Adjusted for race (non-Hispanic White, Black/African American, other race including women who identified as non-Black Hispanic, Asian, Native Hawaiian/Pacific Islander, or American Indian/Alaska Native) and education (less than or equal to high school; associate’s degree/technical degree/some college; bachelor’s degree or higher), and criteria air pollutants (PM2.5, PM10, and NO2).

f

p-for-heterogeneity tests the null hypothesis that there is no difference in association by ER receptor status (IQR increase: p=0.06, 0.1 mBq/m3 increase: p=0.06, Quintiles: p=0.19) and by time spent living in home (<10 y vs. 10 y) [(Overall: IQR increase: p=0.9, 0.1 mBq/m3 increase: p=0.9, Quintiles: p=0.7) (ER+: IQR increase: p=0.3, 0.1 mBq/m3 increase: p=0.3, Quintiles: p=0.9) (ER: IQR increase: p=0.2, 0.1 mBq/m3 increase: p=0.2, Quintiles: p=0.8).

Discussion

In this prospective study of U.S. women, higher estimated exposure to ambient PR-β was associated with an elevated risk of ER breast cancer. This finding was robust to adjustment for several criteria air pollutants that were previously associated with breast cancer risk in this cohort.2 These results are intriguing, given the widespread nature of air pollution, limited research on PR, and lack of established risk factors for ER breast cancer.

Experimental studies suggest that ionizing radiation exposure is more relevant to the development of ER vs. ER+ tumors,6 and county-level estimates of residential radon have also been associated with ER breast cancer.3 However, a nested case–control study within a large study of childhood cancer survivors did not observe differences in the radiation dose–response for ER+ and ER cancers.7

We employed a novel exposure model to estimate residential PR-β in a nationwide cohort, allowing us to consider a range of relevant exposure levels. We also had extensive covariate information to address potential confounding, including by residential air pollution exposure. A limitation is that we relied on ambient PR-β estimated for the home at the time of study enrollment as a proxy for long-term exposure, which could result in nondifferential misclassification and attenuation of relative risks. However, over 50% of participants reported living at their enrollment address for at least 10 y. Further, annual PR is a joint complex function of source radionuclides, atmospheric movement, and abundance of atmospheric aerosol (PM).5 Although long-term trends have been observed in PR, the spatial pattern of PR is relatively stable because the spatial patterns of key predictors (e.g., uranium, relative humidity) do not change remarkably from year to year. Therefore, we assumed that the spatial contrast in exposure was fairly stable in our population over time. The exposure model uses PM-bound gross beta activity as a surrogate measure for total PR; beta particles are relatively low energy but could be a proxy for alpha and gamma radiation,8 which may contribute to cancer risk. The ratio between beta particles and alpha particles was shown to be stable in a recent study.8 When inhaled, alpha particles can be diffused to blood and transported to other organs, supporting plausibility for our observed associations.9

This study suggests a possible role of radioactive particles in the development of ER breast cancer, although our data did not reflect a dose–response relationship. More research is needed to confirm these findings.

References

  • 1.IARC (International Agency for Research on Cancer) Working Group on the Evaluation of Carcinogenic Risks to Humans. 2016. Outdoor air pollution. IARC Monogr Eval Carcinog Risks Hum 109:9–444, PMID: . [PMC free article] [PubMed] [Google Scholar]
  • 2.White AJ, Keller JP, Zhao S, Carroll R, Kaufman JD, Sandler DP. 2019. Air pollution, clustering of particulate matter components, and breast cancer in the sister study: a U.S.-wide cohort. Environ Health Perspect 127(10):107002, PMID: , 10.1289/EHP5131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.VoPham T, DuPré N, Tamimi RM, James P, Bertrand KA, Vieira V, et al. 2017. Environmental radon exposure and breast cancer risk in the Nurses’ Health Study II. Environ Health 16(1):97, PMID: , 10.1186/s12940-017-0305-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Thun MJ, Henley SJ, Travis WD. 2017. Lung Cancer. In: Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press. [Google Scholar]
  • 5.Li L, Blomberg AJ, Lawrence J, Réquia WJ, Wei Y, Liu M, et al. 2021. A spatiotemporal ensemble model to predict gross beta particulate radioactivity across the contiguous United States. Environ Int 156:106643, PMID: , 10.1016/j.envint.2021.106643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Barcellos-Hoff MH. 2013. Does microenvironment contribute to the etiology of estrogen receptor-negative breast cancer? Clin Cancer Res 19(3):541–548, PMID: , 10.1158/1078-0432.CCR-12-2241. [DOI] [PubMed] [Google Scholar]
  • 7.Veiga LH, Curtis RE, Morton LM, Withrow DR, Howell RM, Smith SA, et al. 2019. Association of breast cancer risk after childhood cancer with radiation dose to the breast and anthracycline use: a report from the Childhood Cancer Survivor Study. JAMA Pediatr 173(12):1171–1179, PMID: , 10.1001/jamapediatrics.2019.3807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Liu M, Kang CM, Wolfson JM, et al. 2020. Measurements of gross α- and β-activities of archived PM2.5 and PM10 Teflon filter samples. Environ Sci Technol 54(19):11780–11788, PMID: , 10.1021/acs.est.0c02284. [DOI] [PubMed] [Google Scholar]
  • 9.NRC (National Research Council). 1999. Dosimetry of Inhaled Radon and Its Associated Risk. https://www.ncbi.nlm.nih.gov/books/NBK230518/ [accessed 3 January 2022]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES